ObjectiveTo investigate the clinical significance of target glycemic control in care bundle treatment of elderly patients with severe pneumonia. Methods60 patients with severe pneumonia were enrolled. Subjects eligible for this study were elderly patients of severe pneumonia with no prior history of diabetes and had glucose concentrations of (12.6±5.9) mmol/L on admission. Subjects were randomly assigned to control group (n=30) and observation group (n=30). Both groups were received conventional treatment, including oxygen therapy, anti-infection, dissolve sputum, correct acid-base balance, keep water and electrolyte balance and nutritional support. The control group was adopted intensive glucose control, glucose was controlled at (4.0-6.1) mmol/L, while observation group was received target glycemic control, glucose was controlled at (6.1-10.0) mmol/L. The hypoglycemia, length of RICU stay and mortality of two groups were compared after treatment. ResultsThe incidence of hypoglycemia and mortality in observation group were lower than that of control group, but there was no significant difference between two groups (P＞0.05); the control group had longer length of RICU stay compared to observation group, the difference was statistically significant (P＜0.05). ConclusionsThe target glycemic control in care bundle treatment of severe pneumonia in the elderly can reduce the incidence of hypoglycemia, shorten length of RICU stay and reduce mortality.

• ref